Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents [note 8] $ 5,284 $ 15
Restricted cash [note 8 and 14] 222  
Amounts receivable 9  
Prepaid expenses 393 3
Total current assets 5,908 18
Restricted cash [note 8] 50  
Property and equipment, net [note 9] 59  
Other assets [note 10] 309  
License agreement [note 2, 5, 6 and 7] 2,532 2,755
Goodwill [note 2 and 6] 1,034 1,034
Total assets 9,892 3,807
Current liabilities:    
Accounts payable 213 95
Accrued liabilities other 438 1,121
Accrued clinical liabilities 877  
Accrued compensation 458  
Salaries Payable   1,028
Stockholder loans with related parties [note 13]   829
Current portion of long-term obligations [note 14] 27  
Total current liabilities 2,013 3,073
Deferred tax liability   124
Total liabilities 2,013 3,197
Commitments and contingencies [note 14]
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 11,956,752 and 21,230 issued at December 31, 2017 and December 31, 2016, respectively, and 11,947,932 and 21,230 outstanding at December 31, 2017 and December 31, 2016, respectively 12  
Additional paid-in capital 20,556 2,667
Accumulated deficit (12,694) (2,062)
Accumulated other comprehensive income 5 5
Total stockholders' equity 7,879 610
Total liabilities and stockholders' equity $ 9,892 $ 3,807